Janux Therapeutics Long Term Deferred Charges (Quarterly) Analysis

Janux Therapeutics, Inc. (JANX)

13.98 +0.54 (+4.02%) USD | NASDAQ | Jan 07, 16:00

13.97 -0.01 (-0.07%) After-Hours: 20:00

View Long Term Deferred Charges (Quarterly) for JANX.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Long Term Deferred Charges (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Long Term Deferred Charges (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Long Term Deferred Charges (Quarterly) Benchmarks

Start Trial

Eli Lilly & Co.	--
Stoke Therapeutics, Inc.	--
Ionis Pharmaceuticals, Inc.	--
MannKind Corp.	--
Madrigal Pharmaceuticals, Inc.	--